Generally accepted accounting concepts was 74.9 %. Adjusted selling, general and administrative expense was 26.5 % of sales in the fourth quarter, reflecting continued investment inside our growth brands. On a GAAP basis, SG&A was 28.3 % of sales. Research and advancement was 15.6 % of sales in the quarter, reflecting funding actions to get our emerging mid – and late-stage pipeline assets and the continued quest for additional HUMIRA indications. Net interest expenditure was $68 million, and the adjusted tax price was 22.2 % in the quarter. On a GAAP basis, the fourth-quarter tax rate was 21.6 %. Fourth-quarter diluted income per share were $0.70 on a GAAP basis. Adjusted diluted income per share, excluding intangible asset amortization expenditure and other specified items, were $0.82.The Daily Health Policy Report is published for Kaisernetwork.org, a free of charge service of The Henry J. Kaiser Family Foundation. Copyright 2009 Advisory Board Kaiser and Company Family members Foundation. All rights reserved.
A return to the doctor’s home call may aid health care reform Dr. Peter Boling provides house calls for some of Richmond’s oldest and sickest sufferers as a geriatrician and head of general medication at Virginia Commonwealth University INFIRMARY. The idea is not cost-savings just, but to provide a financial incentive to persuade even more doctors to return to the type or kind of work.